A prognostic risk model for glioma patients by systematic evaluation of genomic variations
Summary: The overall survival rate of gliomas has not significantly improved despite new effective treatments, mainly due to tumor heterogeneity and drug delivery. Here, we perform an integrated clinic-genomic analysis of 1, 477 glioma patients from a Chinese cohort and a TCGA cohort and propose a p...
Main Authors: | Baifeng Zhang, Weiqing Wan, Zibo Li, Zhixian Gao, Nan Ji, Jian Xie, Junmei Wang, Bin Wang, Dora Lai-Wan Kwong, Xinyuan Guan, Shengjie Gao, Yuanli Zhao, Youyong Lu, Liwei Zhang, Karin D. Rodland, Shirley X. Tsang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004222019538 |
Similar Items
-
Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics
by: Jianqiang Wu, et al.
Published: (2020-04-01) -
Role of neuronavigation in the surgical management of brainstem gliomas
by: Mingxin Zhang, et al.
Published: (2023-05-01) -
Susceptibility to preoperative seizures in glioma patients with elevated homocysteine levels
by: Xiaohan Chi, et al.
Published: (2023-12-01) -
Single‐Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma
by: Yongxu Jia, et al.
Published: (2023-03-01) -
Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
by: Hanwen Lu, et al.
Published: (2022-11-01)